TherapeuticsMD Inc.

NASDAQ: TXMD · Real-Time Price · USD
1.17
0.02 (1.72%)
At close: Aug 15, 2025, 3:58 PM
1.18
0.86%
After-hours: Aug 15, 2025, 07:44 PM EDT

TherapeuticsMD Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
952K 393K 667K 547K 234K 313K 502K -53K 437K 416K 1.15M 20.92M 28.56M 19.33M 18.68M 25.41M 23M 19.87M
Cost of Revenue
96K n/a 133K n/a n/a 133K 637K 130K 128K 27K 3.43M 3.79M 4.74M 4.86M 4.74M 5.28M 4.13M 4.69M
Gross Profit
856K 393K 567K 547K 234K 180K -135K -183K 309K 389K -2.28M 17.13M 23.82M 14.47M 13.94M 20.12M 18.87M 15.18M
Operating Income
-695K -871K -319K -859K -2.44M -1.14M -1.61M -1.77M -2.47M -2.67M 111.58M -20.75M -18.84M -26.23M -35.39M -39.92M -35.18M -29.28M
Interest Income
n/a n/a n/a n/a n/a n/a 300K n/a n/a n/a n/a 4.83M n/a n/a n/a n/a n/a n/a
Pretax Income
545K -668K 83K -567K -1.05M -809K -1.58M -1.43M -2.41M -2.31M -33.51M -29.23M 112.83M -49.02M -42.96M -47.42M -42.65M -39.38M
Net Income
551K -653K 252K -609K -1.09M -734K -883K -3.38M -2.41M -3.6M -33.22M -28.96M 112.28M -71.81M -42.96M -47.42M -42.65M -39.38M
Selling & General & Admin
1.55M 1.08M 879K 1.31M 1.23M 1.32M 1.48M 1.59M 2.78M 3.06M -59.24M 36.76M 41.08M 39.3M 47.91M 58.44M 52.04M 42.41M
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -4.09M 1.11M 1.58M 1.4M 1.42M 1.6M 2.01M 2.05M
Other Expenses
96K 183K 107K 96K 1.44M n/a n/a 359K 103K 27K 3.47M n/a -16K n/a 8K 19K 123K 122K
Operating Expenses
1.65M 1.26M 879K 1.41M 2.67M 1.32M 1.48M 1.72M 2.91M 3.08M -63.34M 37.88M 42.66M 40.7M 49.33M 60.05M 54.05M 44.46M
Interest Expense
2K 2K n/a 3K 5K n/a 85K 20K 45K 50K 34.17M 2.25M 3.77M 5.36M 7.58M 6.04M 7.6M 10.23M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a -1.58M n/a n/a n/a -61.7M 19.13M 23.68M 18.89M 22M 30M 32.16M 24.02M
Cost & Expenses
1.65M 1.26M 986K 1.41M 2.67M 1.46M 2.11M 1.72M 2.91M 3.08M -75.33M 41.66M 47.4M 45.56M 54.07M 65.33M 58.18M 49.14M
Income Tax Expense
-6K -32K -31K n/a n/a n/a -43K n/a n/a n/a -290K -260K 550K 22.79M n/a n/a n/a n/a
Shares Outstanding (Basic)
11.57M 11.55M 11.53M 11.53M 11.53M 11.53M 11.53M 10.7M 10.22M 9.75M 9.37M 9.25M 8.75M 8.59M 8.55M 8.44M 7.88M 6.94M
Shares Outstanding (Diluted)
11.57M 11.55M 11.53M 11.53M 11.53M 11.53M 11.53M 10.7M 10.22M 9.75M 9.37M 9.26M 9.06M 8.61M 8.55M 8.44M 7.88M 6.95M
EPS (Basic)
0.05 -0.06 0.02 -0.05 -0.09 -0.06 -0.08 -0.32 -0.24 -0.37 -3.55 -3.13 12.83 -8.36 -5.03 -5.62 -5.41 -5.67
EPS (Diluted)
0.05 -0.06 0.02 -0.05 -0.09 -0.06 -0.08 -0.32 -0.24 -0.37 -3.55 -3.13 12.39 -8.34 -5.03 -5.62 -5.41 -5.67
EBITDA
643K -571K -974K -474K -865K -676K -862K -1.28M -2.24M -2.23M 109.59M -20.75M -14.57M -17.55M -34.38M -39.92M -35.18M -29.28M
EBIT
547K -666K -1.07M -570K -1.04M -809K -1.5M -1.41M -2.37M -2.26M -34.81M -20.93M -14.86M -17.88M -35.38M -41.38M -36.47M -30.43M
Depreciation & Amortization
96K 95K 100K 96K 180K 133K 637K 130K 128K 27K -1.99M 1.03M 1.05M 1.1M 1M 1.03M 1.32M 1.24M